Can you clarify if you or your company recieved any financial gain from publishing the recent report in question?
Also, why did you use REO pricing in your revenue forecasts when the R&D pilot plant product is a 52% mixed concentrate?
Can you clarify if you or your company recieved any financial...
-
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NTU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
0.001(5.00%) |
Mkt cap ! $135.9M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.1¢ | 2.0¢ | $19.50K | 965.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 3017883 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 3221496 | 14 |
View Market Depth
| Last trade - 10.07am 25/11/2024 (20 minute delay) ? |
| NTU (ASX) Chart |
